StockCIK 1422143

Kura Oncology, Inc. (KURA): Insider Trades and Fund Holdings

In the past 12 months, Kura Oncology, Inc. insiders reported 2 open-market purchases worth $2.35M and 11 sales worth $1.71M; 5 of the sales were reported as made under a 10b5-1 trading plan.

2Insider buys, 12 months

$2.35MBought by insiders, 12 months

$1.71MSold by insiders, 12 months

1Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 29, 2026.

Recent KURA insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Sep 29	Sep 29	Mollie LeoniChief Medical Officer	Chief Medical Officer	▼ SELL	28,802	10.75	$310K	−17%	Form 4 ↗
Sep 29	Sep 28	Brian T. PowlChief Commercial Officer	Chief Commercial Officer	▼ SELL	17,020	10.53	$179K	−10%	Form 4 ↗
Sep 29	Sep 29	Brian T. PowlChief Commercial Officer	Chief Commercial Officer	▼ SELL	15,430	10.75	$166K	−10%	Form 4 ↗
Sep 29	Sep 28	Mollie LeoniChief Medical Officer	Chief Medical Officer	▼ SELL	12,448	10.50	$131K	−6.8%	Form 4 ↗
Sep 29	Sep 28	Teresa Brophy BairGeneral Counsel	General Counsel	▼ SELL10b5-1	8,442	10.50	$89K	−4.3%	Form 4 ↗
Sep 29	Sep 28	Kathleen FordCOO	COO	▼ SELL10b5-1	6,906	10.50	$72K	−4.5%	Form 4 ↗
Sep 29	Sep 28	Thomas James DoyleSVP	SVP	▼ SELL	4,607	10.50	$48K	−3.1%	Form 4 ↗
Sep 29	Sep 29	Kathleen FordCOO	COO	▼ SELL10b5-1	3,668	10.75	$39K	−2.5%	Form 4 ↗
Sep 25	Sep 24	Francis BurrowsChief Scientific Officer	Chief Scientific Officer	▼ SELL	20,726	10.83	$225K	−33%	Form 4 ↗
Aug 24	Aug 24	Troy Edward WilsonCEO	CEO (ind.)	▲ BUY	100,000	12.39	$1.24M	+26%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

All 13 KURA insider trades →

Insiders who traded in the past year

Insider	Role	Buys	Bought	Sells	Sold	Latest
Mollie Leoni	Chief Medical Officer	0	$0	2	$440K	Sep 29, 2026
Brian T. Powl	Chief Commercial Officer	0	$0	3	$397K	Sep 29, 2026
Teresa Brophy Bair	General Counsel	0	$0	2	$486K	Sep 29, 2026
Kathleen Ford	COO	0	$0	2	$112K	Sep 29, 2026
Thomas James Doyle	SVP	0	$0	1	$48K	Sep 29, 2026
Francis Burrows	Chief Scientific Officer	0	$0	1	$225K	Sep 25, 2026
Troy Edward Wilson	CEO	2	$2.35M	0	$0	Aug 24, 2026

Tracked funds that report KURA

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

Fund	Quarter	Shares	Value	% of portfolio	Change
Renaissance Technologies	Q2 2026	1,663,765	$18.3M	0.03%	▲ +5.1%

Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →